WE
AUTL

Wealth Effects’s Autolus Therapeutics AUTL Stock Holding History

Wealth Effects’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Hold
10,000
– – ﹤0.01% 254
2026
Q1 		$13.8K Hold
10,000
– – ﹤0.01% 237
2025
Q4 		$19.9K Sell
10,000
-6,000
-38% -$9.22K 0.01% 218
2025
Q3 		$26.1K Buy
16,000
+2,500
+19% +$4.88K 0.01% 217
2025
Q2 		$30.8K Sell
13,500
-22,800
-63% -$37.7K 0.01% 205
2025
Q1 		$56.3K Sell
36,300
-6,500
-15% -$13.2K 0.02% 197
2024
Q4 		$101K Sell
42,800
-8,200
-16% -$27.7K 0.04% 207
2024
Q3 		$185K Buy
51,000
+2,000
+4% +$7.98K 0.06% 200
2024
Q2 		$171K Buy
49,000
+8,000
+20% +$34.5K 0.06% 193
2024
Q1 		$262K Sell
41,000
-2,000
-5% -$12.5K 0.1% 167
2023
Q4 		$277K Sell
43,000
-4,000
-9% -$15.3K 0.1% 162
2023
Q3 		$110K Hold
47,000
– – 0.05% 179
2023
Q2 		$112K Buy
47,000
+2,000
+4% +$4.75K 0.05% 188
2023
Q1 		$82.8K Buy
45,000
+2,750
+7% +$5.38K 0.04% 188
2022
Q4 		$80.3K Sell
42,250
-1,350
-3% -$3.41K 0.05% 184
2022
Q3 		$93K Buy
43,600
+5,500
+14% +$16.3K 0.06% 176
2022
Q2 		$108K Buy
38,100
+6,450
+20% +$19.6K 0.07% 179
2022
Q1 		$132K Buy
31,650
+8,700
+38% +$36.6K 0.06% 193
2021
Q4 		$119K Buy
+22,950
New +$138K 0.05% 207

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wealth Effects's AUTL Position: Q2 2026 in Review

Wealth Effects held its Autolus Therapeutics (AUTL) position steady in Q2 2026 at 10,000 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #254.

Wealth Effects first reported a position in AUTL in Q4 2021 and has held it in 19 quarters since. The position peaked at $277K in Q4 2023. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Wealth Effects held 10,000 shares of Autolus Therapeutics worth $16K as of Q2 2026.
  • Wealth Effects left its Autolus Therapeutics share count unchanged in Q2 2026.
  • Autolus Therapeutics made up ﹤0.01% of Wealth Effects's portfolio in Q2 2026, its #254 holding.
  • Wealth Effects first reported a position in Autolus Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Wealth Effects's Autolus Therapeutics position peaked at $277K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Wealth Effects's 13F filing for Q2 2026, filed 6 Aug 2026.